Andere talen Cannara Biotech Inc.

Aandelen

LOVE

CA13765U2002

Beurs gesloten - Toronto S.E. Andere beurzen 21:59:12 07-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,76 ^CAD	+2,70%		-2,56%	-8,43%

29/04	Cannara Biotech wordt negatief en rapporteert een groter nettoverlies in Q2 vergeleken met een jaar geleden, ondanks een omzetstijging van 51%	MT
29/04	Cannara Biotech Inc. rapporteert resultaten voor het tweede kwartaal en de zes maanden eindigend op 29 februari 2024	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Cannara Biotech Turns Negative As Reports Wider Q2 Net Loss Vs a Year Ago, Despite Revenue up 51%	29/04
Cannara Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024	29/04
Cannara Biotech Reports Q2 2024 Financial Results	29/04
Cannara Biotech CFO Nicholas Sosiak: Unveiling Success Strategies and Future Plans	08/02
Cannara Biotech Inc. Reports Earnings Results for the First Quarter Ended November 30, 2023	29/01
Cannara Biotech to Host Investor Webcast on Thursday December 14th, 2023	11/12
Cannara Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2023	07/12
Cannara Biotech's Fiscal Q4 Profit, Revenue Grows; Up 9.4%	07/12
Cannara Biotech Inc. Reports Earnings Results for the Fourth Quarter Ended August 31, 2023	07/12
Tranche Update on Cannara Biotech Inc.'s Equity Buyback Plan announced on November 30, 2022.	27-07-23
Cannara Biotech Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2023	27-07-23
Cannara Biotech Inc. Reports Record Q3 2023 Financial Results with Net Revenues of $15.9 Million and Net Income of $2.9 million	27-07-23
Cannara Biotech Inc Announces Participation in the LD Micro Invitational XIII	23-05-23
Tranche Update on Cannara Biotech Inc.'s Equity Buyback Plan announced on November 30, 2022.	24-04-23
Cannara Biotech Inc. Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2023	24-04-23
Cannara Biotech Down Near 8% As Enters into an Automatic Share Purchase Plan	28-02-23
Cannara Biotech Inc. Enters into an Automatic Share Purchase Plan	28-02-23
Cannara biotech inc. Announces results of annual shareholder meeting and conversion into equity of a $5m convertible debenture at $0.18 cent per common share	13-02-23
Cannara Biotech Converts CA$5 Million Debenture, Plus Interest, into Nearly 30 Million Shares for Olymbec Investments	10-02-23
Tranche Update on Cannara Biotech Inc.'s Equity Buyback Plan announced on November 30, 2022.	23-01-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Cannara Biotech Inc.

Aandelen

LOVE

CA13765U2002

Andere talen

Filters